Tracking outcomes in advanced neuroendocrine cancer
Part of Cancer clinical trials.
This study is tracking patients with advanced neuroendocrine tumors to see which treatments help them live longer without severe side effects, and how these side effects affect daily life. It aims to find the best treatment approaches for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neuroendocrine tumor that cannot be fully removed by surgery or has spread to other parts of the body.
- You either have not had any treatment for this tumor (except a hormone therapy called a somatostatin analogue, or surgery), or you were diagnosed less than 6 months ago.
- Your tumor is a 'well differentiated' type (which means it tends to grow slowly), confirmed by a biopsy.
- You do not have any severe medical conditions that would prevent you from participating.
- You are 18 years of age or older.
- You are willing to have your medical data collected in a French national database for research purposes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with neuroendocrine tumors tolerate oral (pill) anti-cancer drugs and how these drugs affect their quality of life. It also tests a patient education program to help manage side effects and improve well-being.
This study follows people after surgery to remove neuroendocrine tumors (NETs) from the stomach, intestines, or pancreas. It aims to understand long-term outcomes and quality of life.
This trial tests a new calcium-based medicine (AUR103) for people with neuroendocrine tumours that have spread and are no longer responding to standard treatments. It aims to see if this medicine can help control the disease.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This study looks at how tumor and patient factors affect treatment response in well-differentiated GEP-NENs (neuroendocrine tumors of the digestive system). It may help doctors understand which treatments work best for people like you.
Hear when a new Neuroendocrine (NE) Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.